Interview series explores personalized therapeutic strategies in renal ciliopathies, highlighting key findings from recent research.
First Person is a series of interviews with the first authors of a selection of papers published in Journal of Cell Science, helping researchers promote themselves alongside their papers. Praveen Dhondurao Sudhindar is first author on ‘ Urinary renal epithelial cells can be used for NPHP1 phenotyping and a personalized therapeutic strategy’, published in JCS. Praveen is a post-doctoral fellow in the lab of John Sayer at Biosciences, Centre for Life, Newcastle University, UK, where he explores renal ciliopathies through cellular models to uncover novel therapeutic strategies.
No takes yet. Share an insight, caveat, or question.
A 2025 study studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: